Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...

A new federally funded research effort in Rochester is aiming to tackle one of the biggest gaps in treating age-related macular degeneration — stopping vision loss before it starts. Researchers at ...

A laser treatment for this common eye disease will start clinical trials in Finland next spring ––researchers hope it could be available to sufferers in as little as three years Around a third of ...

The 2024 American Academy of Ophthalmology (AAO) Preferred Practice Patterns provide guidance for physicians about best practices in the treatment of age-related macular degeneration (AMD). The ...

Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research BrightFocus Foundation today ...

Dry age-related macular degeneration (AMD) management is currently based on regular follow-up for early detection of choroidal neovascularization (CNV), addressing the risk factors and prescribing ...

Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of age-related macular degeneration (AMD). A new study, ...

Significantly lower AMD risk compared with other agents in cohort study ...

BrightFocus Foundation today announced $15.2 million in new research grants for Alzheimer’s disease, macular degeneration, and glaucoma, reinforcing its commitment to advancing scientific discovery ...